Igene Biotechnology Inc (IGNE)
0.0002
+0.00 +0.00%
OTC Markets
May 22, 20:00
Delayed 15m
USD
View All Key Stats
Key Stats
| Income Statement | |
| Revenue (TTM) | -- |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | -- |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | -- |
| Profitability | |
| Gross Profit Margin (Quarterly) | -- |
| Profit Margin (Quarterly) | -- |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield | 0.00% |
| Price and Valuation | |
| Market Cap | 0.3131M |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio | -- |
| PE Ratio | -- |
| Price to Book Value | -- |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio | -- |
| Free Cash Flow (Quarterly) | -- |
| Return on Equity | Upgrade |
Ratings & Reports
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
- One Page Report Download
Advertisement
Edit
Profile
- URL: http://www.igene.com
- Investor Relations URL: N/A
- HQ State/Province: Maryland
- Sector: Basic Materials
- Industry: Agricultural Inputs
- Equity Style: N/A
- Next Earnings Release: N/A
- Last Earnings Release: N/A
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
- Description: Igene Biotechnology Inc develops, produces and markets value-added specialty biochemical products. The company is a supplier of natural astaxanthin, an essential nutrient in different feed applications and a source of pigment for coloring farmed salmon species. The company's natural astaxanthin product is marketed as AstaXin and is made from yeast, and used as a source of pigment for coloring farmed salmonids. The company is engaged in research and development in the areas of fermentation technology, nutrition and health and the marketing of products and applications worldwide.
Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 0.0002 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Other Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- IGNE Tweets Stocktwits
Advertisement
